StageZero Life Sciences Ltd.
SZLS
Rang in aandelen
#36082
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise... StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples. Its flagship product, Aristotle, exemplifies this innovation; it's a comprehensive multi-cancer panel that simultaneously screens for numerous cancers from a single blood draw, boasting impressive sensitivity and specificity for each identified malignancy. Beyond Aristotle, the company's portfolio includes ColonSentry, a blood-based test gauging colorectal cancer risk; COVID-19 PCR testing and general blood analysis services; the Prostate Health Index for prostate cancer screening; and BreastSentry, designed to evaluate a woman's susceptibility to breast cancer. Established in 1998, StageZero Life Sciences Ltd. maintains its headquarters in Richmond Hill, Canada.
Aandeelprijs
$0.02770208
Laatst gesynchroniseerd: 2025-03-10
Marktkapitalisatie
$2.92M
Verandering (1 dag)
-0.46%
Verandering (1 jaar)
443.18%
Land
CA
Handel StageZero Life Sciences Ltd. (SZLS)
Categorie
Healthcare
Marktkapitalisatie van StageZero Life Sciences Ltd.(SZLS)
Marktkapitalisatie: $2.92M
Vanaf October 2026 heeft StageZero Life Sciences Ltd. een marktkapitalisatie van $2.92M. Dit maakt StageZero Life Sciences Ltd. volgens onze gegevens het 36082nd meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van StageZero Life Sciences Ltd. van 2009 tot 2026
SZLS vergeleken met de top 5 populairste stocks
| Prijs voor SZLS | Aandeel B | Marktkapitalisatie van B | uitslagen | |
|---|---|---|---|---|
$41,827.20
$123.53K
|
$5.167T | +4,182,720,306.69% | ||
|
$40,594.65
$123.53K
|
$5.015T | +4,059,465,112.29% | ||
|
$33,257.53
$123.53K
|
$4.108T | +3,325,752,716.77% | ||
|
$31,585.92
$123.53K
|
$3.902T | +3,158,592,145.39% | ||
|
$21,771.15
$123.53K
|
$2.689T | +2,177,115,360.65% |
